Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · IEX Real-Time Price · USD
1.440
+0.050 (3.60%)
Mar 28, 2024, 12:19 PM EDT - Market open

Context Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
7.297.793.630.932.97
Research & Development
17.787.093.811.642.41
Other Operating Expenses
0.060.52.9600
Operating Expenses
25.1315.3810.42.575.38
Operating Income
-25.13-15.38-10.4-2.57-5.38
Interest Expense / Income
000.060.661.1
Other Expense / Income
-1.16-0.55-0.01-9.88-0.09
Pretax Income
-23.96-14.84-10.466.64-6.38
Net Income
-23.96-14.84-10.466.64-6.38
Shares Outstanding (Basic)
161630-
Shares Outstanding (Diluted)
161632-
Shares Change
-463.44%37.90%--
EPS (Basic)
-1.50-0.93-3.693.07-
EPS (Diluted)
-1.50-0.93-3.69-3.96-
Free Cash Flow
-21.05-13.59-8.8-1.03-2.84
Free Cash Flow Per Share
-1.32-0.85-3.10-2.97-
EBITDA
-23.9-14.75-10.397.31-5.28
Depreciation & Amortization
0.060.09000
EBIT
-23.96-14.84-10.397.31-5.28
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).